These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21641344)

  • 1. Projecting heart failure into bankruptcy in 2012?
    Stevenson LW
    Am Heart J; 2011 Jun; 161(6):1007-11. PubMed ID: 21641344
    [No Abstract]   [Full Text] [Related]  

  • 2. Defibrillators in heart failure and quality of life.
    Matlock DD
    N Engl J Med; 2009 Jan; 360(2):187-8; author reply 189. PubMed ID: 19129534
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of ICDs.
    Stevenson LW; Stevenson WG
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16411295
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic impact of heart failure in the United States: time for a different approach.
    O'Connell JB; Bristow MR
    J Heart Lung Transplant; 1994; 13(4):S107-12. PubMed ID: 7947865
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
    Sanders GD; Kong MH; Al-Khatib SM; Peterson ED
    Am Heart J; 2010 Jul; 160(1):122-31. PubMed ID: 20598982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry.
    Pedretti RF; Curnis A; Massa R; Morandi F; Tritto M; Manca L; Occhetta E; Molon G; De Ferrari GM; Sarzi Braga S; Raciti G; Klersy C; Salerno-Uriarte JA;
    Europace; 2010 Aug; 12(8):1105-11. PubMed ID: 20400768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The year in heart failure.
    Owens AT; Jessup M
    J Am Coll Cardiol; 2012 Jul; 60(5):359-68. PubMed ID: 22835667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiac resynchronization therapy and reduction of mortality in heart failure: a proven association].
    Mele D; Toselli T; Pratola C; Artale P; Ferrari R
    G Ital Cardiol (Rome); 2007 Dec; 8(12):760-9. PubMed ID: 18085101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on current care guidelines. Current care guideline: cardiac pacemaker therapy].
    Duodecim; 2010; 126(4):391-2. PubMed ID: 20486489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy.
    Bernard ML; Gold MR
    Heart Fail Clin; 2011 Apr; 7(2):241-50, ix. PubMed ID: 21439502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Coceani: Has CRT earned a class I recommendation?
    Dimarco JP; Gold MR
    Circ Heart Fail; 2010 Jul; 3(4):559-60. PubMed ID: 20647492
    [No Abstract]   [Full Text] [Related]  

  • 13. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

  • 14. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators.
    Mack MJ
    N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15888706
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances and stagnations in heart failure.
    Goldberg RJ; Meyer TE
    Arch Intern Med; 1997 Jan; 157(1):17-9. PubMed ID: 8996037
    [No Abstract]   [Full Text] [Related]  

  • 17. Observation unit economics.
    Sieck SG; Moseley MG
    Heart Fail Clin; 2009 Jan; 5(1):101-11, vii. PubMed ID: 19026390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the advantages of peritoneal dialysis in the treatment of chronic refractory heart failure].
    Sánchez JE; Rodríguez C; González I; Fernández-Viña A; Núñez M; Peláez B
    Nefrologia; 2010; 30(5):487-9. PubMed ID: 20882088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?].
    Botto GL; Luzi M; Russo G; Mariconti B
    G Ital Cardiol (Rome); 2010 Apr; 11(4):306-9. PubMed ID: 20677576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.